Morphinoid compounds
US6696457B1 · kind B1 · utility
0Cited by
1References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 2, 2002 |
| Grant date | Feb 24, 2004 |
| Priority date | — |
| Expiry date | Apr 2, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Heterocycle condensed morphinoid derivatives of formula (I) have therapeutic utility as analgesics, in collagen disease, as anti-allergic and anti-inflammatory agents, brain cell protectants, in gastritis, diarrhoea, cardiovascular and respiratory diseases, cough, mental illness, epilepsy, for the preservation of organs during transplant operations, and for the treatment of those pathological conditions which customarily can be treated with agonists of the delta opioid receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.